Lowell F. Satler

Showing 1-6 of 6 articles

Interventions for valvular disease

The adjunctive use of Angio-Seal in femoral vascular closure following percutaneous transcatheter aortic valve replacement

Kiramijyan S, Magalhaes M, Ben-Dor I, Koifman E, Escarcega R, Baker N, Torguson R, Okubagzi P, Bernardo N, Satler L, Pichard A, Waksman R

May 16, 2016 | 10.4244/EIJV12I1A16

The effect of complete percutaneous revascularisation with and without intravascular ultrasound guidance in the drug-eluting stent era

Magalhaes M, Minha S, Torguson R, Baker N, Escarcega R, Al Fazir O, Lipinski M, Chen F, Suddath W, Satler L, Pichard A, Waksman R

October 20, 2015 | 10.4244/EIJV11I6A124

Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis

Ben-Dor I, Torguson R, Gaglia M, Gonzalez M, Maluenda G, Bui A, Xue Z, Satler L, Suddath W, Lindsay J, Pichard A, Waksman R

June 30, 2011 | 10.4244/EIJV7I2A37

Impact of drug-eluting stent type on periprocedural myocardial necrosis

Wakabayashi K, Delhaye C, Mahmoudi M, Belle L, Ben-Dor I, Gaglia M, Suddath W, Satler L, Kent K, Pichard A, Lindsay J, Waksman R

May 17, 2011 | 10.4244/EIJV7I1A22

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents

Lemesle G, Torguson R, Bonello L, de Labriolle A, Maluenda G, Ben-Dor I, Collins S, Syed A, Xue Z, Satler L, Pichard A, Waksman R

April 20, 2011

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention

Syed A, Ben-Dor I, Li Y, Collins S, Torguson R, Wakabayashi K, Gonzalez M, Maluenda G, Delhaye C, Belle L, Gaglia M, Jr. J, Xue Z, Kaneshig K, Bernardo N, Kent K, Suddath W, Satler L, Pichard A, Lindsay J, Waksman R

April 20, 2011

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Treatment of secondary mitral regurgitation in patients with heart failure

Marco Metra et al

This Week's JAA's: DLMC in CTO-PCI, Membranous Septum Morphology and TAVI ...

Coronary flow capacity: where to next?

Nils P. Johnson

Joint EAPCI/ACVC expert consensus document on pVADs

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease